Historically, the United States has played a major role in funding HIV prevention and treatment abroad through programs like PEPFAR, the President's Emergency Plan for AIDS Relief. But in his second ...

As competition in both the HIV treatment and prevention fields continues to mount, GSK’s ViiV Healthcare is looking to expand ...

Lenacapavir, a twice-a-year injection could transform HIV prevention, but it will not be available to all.

Medically reviewed by Anju Goel, MD Key Takeaways Early signs of HIV may include fever, rash, and fatigue.Swollen lymph nodes can appear in the early stages of HIV as the body tries to fight the virus ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. A new sequential immunization strategy shows strong promise for an HIV vaccine, a ...

Gilead's twice-yearly shot reduced HIV infections by 96% in a second large study, the company said. The data sets the stage for likely FDA approval of lenacapavir for HIV prevention. Shares rose 3% in ...

Effective treatment means people with HIV can live long lives and cannot sexually transmit the virus when undetectable, yet ...

Opinion: The fight against HIV should be nonpartisan, writes Susie Castillo, who won a Trump-owned pageant in 2003.

In the early decades of the global response to HIV/AIDS, the focus was on saving lives. And rightly so: without antiretroviral treatment (ART), people lived less than a year, on average, from the time ...

More individuals are reaching an older age with HIV, creating new challenges for clinicians who must manage the long-term effects of HIV and antiretroviral therapy (ART) alongside multimorbidity, ...